MacLean’s magazine: How the new impatient patient is disrupting medicine
Patient activists have never been as vocal. But are they truly being heard?
Insert HTML here
Patient activists have never been as vocal. But are they truly being heard?
October 21, 2017In late August, Sue Faber and Jennifer Kravis hauled close to 150 pounds of documents and scientific research into a Health Canada office in Ottawa. The two women, co-founders of Lyme-patient advocacy group LymeHope, had been granted a 15-minute audience with then federal health minister, Dr. Jane Philpott, and Dr. Theresa Tam, head of the Public Health Agency of Canada. They’d lobbied hard for the face time and intended to make the most of it.
August 23, 2017 written by Huib In the USA an unprecedented anti-trust law suit of $57 million is being prepared against the CDC. They are accused of deliberately suppressing the use of an accurate DNA direct diagnostics for Lyme disease. You can read about the aim and potential impact of this lawsuit in this article. “In…
Biologist Vett Lloyd says it’s no longer a localized problem and everyone should be on alert CBC News – Posted: Jun 6, 2013 A New Brunswick biologist says the number of ticks carrying Lyme disease in the province continues to rise and people should be on alert. Vett Lloyd, who has been collecting samples of blacklegged…
[CanLyme note: It is very common for mainstream physicians who subscribe to the Infectious Disease Society of America guidelines to design studies in such a fashion that the outcome is pre-determined. These studies have no value, nor scientific merit. The divide is created intentionally.] Infectious Disease doctor, Sam Donta, responds to article, To the Editor:…
[CanLyme Note: What is missing is a transparent collaborative plan to track patients who are only given a single dose prophylactic antibiotic following a tick bite. CanLyme has dealt with numerous individuals who went on to develop a full-blown Lyme infection after receiving the prophylactic dose only then to be denied further appropriate treatment. Collaboration must…
[CanLyme Note: Judith Miklossy, PhD, was a founding Board member of CanLyme in 2003 and remained until she moved back to her home in Switzerland from British Columbia in 2009. Her research ethics and standards are impeccable and well recognized.] By Jill U. Adams TheScientist In late 2011, Drexel University dermatology professor Herbert Allen was astounded to…
November 21st, 2018 Abstract Human babesiosis is an emerging tick-borne disease caused by apicomplexan parasites of the genus Babesia. Clinical cases caused by Babesia duncani have been associated with high parasite burden, severe pathology and death. In both mice and hamsters, the parasite causes uncontrolled fulminant infections, which ultimately lead to death. Resolving these infections requires knowledge of B. duncani biology, virulence,…